Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J‐STEP/INS): Results of a 16‐week randomized, double‐blind, placebo‐controlled multicentre trial
Yasuo Terauchi; Masahiro Tamura; Masayuki Senda; Ryoji Gunji; Kohei Kaku
Author Information: Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.